MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study

Roberta Biundo, L. Weis, S. Bostantjopoulou, E. Stefanova, C. Falup-Pecurariu, M. G. Kramberger, G. J. Geurtsen, A. Antonini, D. Weintraub, D. Aarsland

Research output: Contribution to journalArticle

Abstract

The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are the most commonly used scales to test cognitive impairment in Lewy body disease (LBD), but there is no consensus on which is best suited to assess cognition in clinical practice and most sensitive to cognitive decline. Retrospective cohort study of 265 LBD patients [Parkinson’s disease (PD) without dementia (PDnD, N = 197), PD with dementia (PDD, N = 40), and dementia with Lewy bodies (DLB, N = 28)] from an international consortium who completed both the MMSE and MoCA at baseline and 1-year follow-up (N = 153). Percentage of relative standard deviation (RSD%) at baseline was the measure of inter-individual variance, and estimation of change (Cohen’s d) over time was calculated. RSD% for the MoCA (21 %) was greater than for the MMSE (13 %) (p = 0.03) in the whole group. This difference was significant only in PDnD (11 vs. 5 %, p <0.01), but not in PDD (30 vs. 19 %, p = 0.37) or DLB (15 vs. 14 %, p = 0.78). In contrast, the 1-year estimation of change did not differ between the two tests in any of the groups (Cohen’s effect

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Neural Transmission
DOIs
Publication statusAccepted/In press - Feb 6 2016

Fingerprint

Lewy Body Disease
Parkinson Disease
Dementia
Cognition
Consensus
Cohort Studies
Retrospective Studies
Cognitive Dysfunction

Keywords

  • Dementia with Lewy bodies
  • MMSE
  • MoCA
  • Parkinson disease
  • Rate of cognitive decline

ASJC Scopus subject areas

  • Biological Psychiatry
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Biundo, R., Weis, L., Bostantjopoulou, S., Stefanova, E., Falup-Pecurariu, C., Kramberger, M. G., ... Aarsland, D. (Accepted/In press). MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. Journal of Neural Transmission, 1-8. https://doi.org/10.1007/s00702-016-1517-6

MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies : a multicenter 1-year follow-up study. / Biundo, Roberta; Weis, L.; Bostantjopoulou, S.; Stefanova, E.; Falup-Pecurariu, C.; Kramberger, M. G.; Geurtsen, G. J.; Antonini, A.; Weintraub, D.; Aarsland, D.

In: Journal of Neural Transmission, 06.02.2016, p. 1-8.

Research output: Contribution to journalArticle

Biundo, R, Weis, L, Bostantjopoulou, S, Stefanova, E, Falup-Pecurariu, C, Kramberger, MG, Geurtsen, GJ, Antonini, A, Weintraub, D & Aarsland, D 2016, 'MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study', Journal of Neural Transmission, pp. 1-8. https://doi.org/10.1007/s00702-016-1517-6
Biundo, Roberta ; Weis, L. ; Bostantjopoulou, S. ; Stefanova, E. ; Falup-Pecurariu, C. ; Kramberger, M. G. ; Geurtsen, G. J. ; Antonini, A. ; Weintraub, D. ; Aarsland, D. / MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies : a multicenter 1-year follow-up study. In: Journal of Neural Transmission. 2016 ; pp. 1-8.
@article{213e88fce2464013acaa245cbcdd1e15,
title = "MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study",
abstract = "The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are the most commonly used scales to test cognitive impairment in Lewy body disease (LBD), but there is no consensus on which is best suited to assess cognition in clinical practice and most sensitive to cognitive decline. Retrospective cohort study of 265 LBD patients [Parkinson’s disease (PD) without dementia (PDnD, N = 197), PD with dementia (PDD, N = 40), and dementia with Lewy bodies (DLB, N = 28)] from an international consortium who completed both the MMSE and MoCA at baseline and 1-year follow-up (N = 153). Percentage of relative standard deviation (RSD{\%}) at baseline was the measure of inter-individual variance, and estimation of change (Cohen’s d) over time was calculated. RSD{\%} for the MoCA (21 {\%}) was greater than for the MMSE (13 {\%}) (p = 0.03) in the whole group. This difference was significant only in PDnD (11 vs. 5 {\%}, p <0.01), but not in PDD (30 vs. 19 {\%}, p = 0.37) or DLB (15 vs. 14 {\%}, p = 0.78). In contrast, the 1-year estimation of change did not differ between the two tests in any of the groups (Cohen’s effect",
keywords = "Dementia with Lewy bodies, MMSE, MoCA, Parkinson disease, Rate of cognitive decline",
author = "Roberta Biundo and L. Weis and S. Bostantjopoulou and E. Stefanova and C. Falup-Pecurariu and Kramberger, {M. G.} and Geurtsen, {G. J.} and A. Antonini and D. Weintraub and D. Aarsland",
year = "2016",
month = "2",
day = "6",
doi = "10.1007/s00702-016-1517-6",
language = "English",
pages = "1--8",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer-Verlag Wien",

}

TY - JOUR

T1 - MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies

T2 - a multicenter 1-year follow-up study

AU - Biundo, Roberta

AU - Weis, L.

AU - Bostantjopoulou, S.

AU - Stefanova, E.

AU - Falup-Pecurariu, C.

AU - Kramberger, M. G.

AU - Geurtsen, G. J.

AU - Antonini, A.

AU - Weintraub, D.

AU - Aarsland, D.

PY - 2016/2/6

Y1 - 2016/2/6

N2 - The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are the most commonly used scales to test cognitive impairment in Lewy body disease (LBD), but there is no consensus on which is best suited to assess cognition in clinical practice and most sensitive to cognitive decline. Retrospective cohort study of 265 LBD patients [Parkinson’s disease (PD) without dementia (PDnD, N = 197), PD with dementia (PDD, N = 40), and dementia with Lewy bodies (DLB, N = 28)] from an international consortium who completed both the MMSE and MoCA at baseline and 1-year follow-up (N = 153). Percentage of relative standard deviation (RSD%) at baseline was the measure of inter-individual variance, and estimation of change (Cohen’s d) over time was calculated. RSD% for the MoCA (21 %) was greater than for the MMSE (13 %) (p = 0.03) in the whole group. This difference was significant only in PDnD (11 vs. 5 %, p <0.01), but not in PDD (30 vs. 19 %, p = 0.37) or DLB (15 vs. 14 %, p = 0.78). In contrast, the 1-year estimation of change did not differ between the two tests in any of the groups (Cohen’s effect

AB - The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are the most commonly used scales to test cognitive impairment in Lewy body disease (LBD), but there is no consensus on which is best suited to assess cognition in clinical practice and most sensitive to cognitive decline. Retrospective cohort study of 265 LBD patients [Parkinson’s disease (PD) without dementia (PDnD, N = 197), PD with dementia (PDD, N = 40), and dementia with Lewy bodies (DLB, N = 28)] from an international consortium who completed both the MMSE and MoCA at baseline and 1-year follow-up (N = 153). Percentage of relative standard deviation (RSD%) at baseline was the measure of inter-individual variance, and estimation of change (Cohen’s d) over time was calculated. RSD% for the MoCA (21 %) was greater than for the MMSE (13 %) (p = 0.03) in the whole group. This difference was significant only in PDnD (11 vs. 5 %, p <0.01), but not in PDD (30 vs. 19 %, p = 0.37) or DLB (15 vs. 14 %, p = 0.78). In contrast, the 1-year estimation of change did not differ between the two tests in any of the groups (Cohen’s effect

KW - Dementia with Lewy bodies

KW - MMSE

KW - MoCA

KW - Parkinson disease

KW - Rate of cognitive decline

UR - http://www.scopus.com/inward/record.url?scp=84957588863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957588863&partnerID=8YFLogxK

U2 - 10.1007/s00702-016-1517-6

DO - 10.1007/s00702-016-1517-6

M3 - Article

AN - SCOPUS:84957588863

SP - 1

EP - 8

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

ER -